Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 25,000 ACHV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 25,000 | n/a |
| Jun 16, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 16,377 | n/a |
| Jun 3, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 9,136 | n/a |
| May 13, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 47,250 | n/a |
| Dec 11, 2025 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 35,000 | n/a |
| Nov 24, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 45,150 | n/a |